Effects of metabolic syndrome on the treatment response of in-patients with major depressive disorder

被引：0
|
作者：
Jung, H. [1 ]
Lee, S. [1 ]
Kim, S. [1 ]
Na, K. [1 ]
Lee, B. [2 ]
机构：
[1] Soonchunhyang Univ, Bucheon Hosp, Dept Psychiat, Bucheon, Gyeonggi Do, South Korea
[2] Eulji Univ, Gangnam Eulji Hosp, Dept Psychiat, Seoul, South Korea
来源：
EUROPEAN NEUROPSYCHOPHARMACOLOGY | 2013年 / 23卷
关键词：
D O I：
10.1016/S0924-977X(13)70545-5
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P.2.b.046
引用
收藏
页码：S346 / S347
页数：2
相关论文
共 50 条
  • [41] Effects of modern antidepressants with different mode of action on cardiovascular parameters in patients with major depressive disorder and response to treatment
    Zeugmann, S.
    Quante, A.
    Schroeder, C.
    Anghelescu, L-G.
    Jordan, J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2007, 17 : S155 - S155
  • [42] Effects of Age on Paroxetine Efficacy in Patients With Major Depressive Disorder Who Do Not Exhibit an Early Response to Treatment
    Tomita, Tetsu
    Sato, Yasushi
    Nakagami, Taku
    Tsuchimine, Shoko
    Kaneda, Ayako
    Kaneko, Sunao
    Nakamura, Kazuhiko
    Yasui-Furukori, Norio
    CLINICAL NEUROPHARMACOLOGY, 2015, 38 (01) : 6 - 10
  • [43] Metabolic syndrome in bipolar disorder and major depressive disorder in current depressive episode: population-based study
    Mondin, T.
    Moreira, F.
    Wiener, C.
    Cardoso, T.
    Jansen, K.
    Souza, L.
    Silva, R.
    BIPOLAR DISORDERS, 2017, 19 : 86 - 86
  • [44] Pharmacological treatment for insomnia in patients with major depressive disorder
    Brietzke, Elisa
    Vazquez, Gustavo H.
    Kang, Melody J. Y.
    Soares, Claudio N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (11) : 1341 - 1349
  • [45] Escitalopram: In the treatment of major depressive disorder in adolescent patients
    Yang L.P.H.
    Scott L.J.
    Pediatric Drugs, 2010, 12 (3) : 155 - 162
  • [46] Long-term effects of physical activity counseling in in-patients with major depressive disorder: The PACINPAT randomized controlled trial
    Gerber, Markus
    Kreppke, Jan-Niklas
    Cody, Robyn
    Faude, Oliver
    Ludyga, Sebastian
    Beck, Johannes
    Hatzinger, Martin
    Imboden, Christian
    Lang, Undine E.
    Mikoteit, Thorsten
    Schweinfurth-Keck, Nina
    Zahner, Lukas
    JOURNAL OF SPORT & EXERCISE PSYCHOLOGY, 2024, 46 : S70 - S70
  • [47] PHARMACOTHERAPY TREATMENT PATTERNS IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Arnaud, A.
    Werneburg, B.
    Suthoff, E.
    Parikh, A.
    Marinaro, X.
    Zhang, X.
    VALUE IN HEALTH, 2021, 24 : S167 - S167
  • [48] Personalized antidepressant treatment for patients with major depressive disorder
    Chin, Tracy
    Huyghebaert, Trudy
    Svrcek, Clark
    Oluboka, Oloruntoba
    CANADIAN FAMILY PHYSICIAN, 2022, 68 (11) : E301 - E309
  • [49] Duloxetine for the treatment of major depressive disorder in older patients
    Nelson, JC
    Wohlreich, MM
    Mallinckrodt, CH
    Detke, MJ
    Watkin, JG
    Kennedy, JS
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 13 (03): : 227 - 235
  • [50] Escitalopram in the treatment of diabetic patients with major depressive disorder
    Pollock, Bruce G.
    Bose, Anjana
    Gordon, John
    Li, Dayong
    Gandhi, Chetan
    NEUROPSYCHOPHARMACOLOGY, 2006, 31 : S98 - S99
12345